Sanofi (SNYNF) Shareholder's Equity Growth (3y) (2012 - 2025)

Sanofi (SNYNF) Shareholder's Equity Growth (3y) (2012 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Sanofi	-	-	9.49 Bn

Historic Data

Download Data

Date	Value
Dec 31, 2025	2.88%
Jun 30, 2025	1.50%
Dec 31, 2024	1.77%
Jun 30, 2024	1.00%
Dec 31, 2023	1.92%
Jun 30, 2023	4.34%
Dec 31, 2022	307.57%
Jun 30, 2022	6.21%
Dec 31, 2021	5.35%
Dec 31, 2020	3.24%
Jun 30, 2020	3.24%
Dec 31, 2019	-73.75%
Jun 30, 2019	1.13%
Dec 31, 2018	1.74%
Dec 31, 2017	-0.93%
Jun 30, 2017	-3.64%
Dec 31, 2016	-7.06%
Jun 30, 2016	-5.76%
Dec 31, 2015	-5.06%
Jun 30, 2015	-4.66%